Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
FRANCE – Sanofi has collaborated with the Californian biotechnology company Scribe Therapeutics to develop new cancer cell therapies. Under the terms of the deal, Sanofi picks up non-exclusive rights to…
Read More
UNITED KINGDOM – Scientists from the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust have genetically modified a strain of the herpes virus to act as a…
Read More
USA – Death rates attributable to cancer in the United States have decreased steadily owing to the strides that have been made in cancer treatments, diagnostic tools, and prevention strategies,…
Read More
USA – President Joe Biden has signed orders to push more government dollars to the US biotechnology industry, as he promoted his initiative to create new treatments and cut the…
Read More
ISRAEL – The Hadassah Cancer Research Institute (HCRI) at the Hadassah University Medical Center in Jerusalem, Israel, is to lead CanceRNA, a global consortium aiming to apply RNA-based therapeutics to…
Read More
INDIA – Researchers from IIIT-Delhi have developed an Artificial Intelligence-based model to detect carcinogens in chemical structures, which could have importance for the pharma industry for the screening of new…
Read More
INDIA -The Tata Memorial Centre (TMC), Vedanta Medical Research Foundation’s flagship initiative, and BALCO Medical Centre (BMC), have entered into a memorandum of understanding (MOU) to drive excellence in cancer…
Read More
SOUTH AFRICA – Roche Pharmaceuticals South Africa has launched its human papillomavirus (HPV) self-sampling solution in countries accepting the CE mark, the multinational healthcare company said on its website. According…
Read More
SOUTH AFRICA – Roche Pharmaceuticals South Africa marks the World Lymphoma Awareness Day (WLAD) with calls to improve the ways lymphomas are diagnosed, treated and tracked as it is the…
Read More
INDIA – Four key anti-cancer drugs and four patented antivirals used in the treatment of tuberculosis, HIV, and hepatitis C are set to get cheaper with their inclusion in the…
Read More